Complete Genomics' Q1 Revenues Drop 43 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Complete Genomics reported after the close of the market Monday that its first-quarter revenues declined 43 percent year over year, falling short of Wall Street's consensus estimate on the top line.

The Mountain View, Calif.-based whole human genome services firm had total revenues of $3.9 million for the three months ended March 31, compared to $6.8 million for the first quarter of 2011. Analysts, on average, expected sales of $4.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.